(Q33407012)

English

Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

L Katragadda

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Z Shahid

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Restrepo

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

J Muzaffar

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Alapat

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

E Anaissie

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

11 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

354-360

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rheumatic manifestations of parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Association of human parvovirus B19 infection with acute meningoencephalitis.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Clinical aspects of parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Human parvovirus B19 infection and autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

The spectrum of parvovirus b19 infection in a pediatric hemato-oncologic ward

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Parvovirus B19 infection after transplantation: a review of 98 cases

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory

1 reference

https://api.crossref.org/works/10.1111%2FTID.12067

21 January 2018

Identifiers

10.1111/TID.12067

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33407012&oldid=1536363448"